Skip to content

CapEx at other companies

Eli Lilly logo
Eli LillyLLY
$2.33B+54.0%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$133.4M+228%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$79K-89.3%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$504K+145%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$2.23M-27.2%
Regenxbio logo
RegenxbioRGNX
$1.24M+20.6%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's capex?
Prime Medicine (PRME) reported capex of $214K in Q1 2026.
How has Prime Medicine's capex changed year-over-year?
Prime Medicine's capex decreased by 91.2% year-over-year, from $2.42M to $214K.
What is the long-term trend for Prime Medicine's capex?
Over 3 years (2022 to 2025), Prime Medicine's capex has grown at a -34.5% compound annual growth rate (CAGR), from $16.1M to $4.53M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.